View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
TI-CE - Paclitaxel 200 / Ifosfamide 2, Testicular Carcinoma, part A
Protocol-ID: 780 V1.2 (Mini), TI-CE (PACL200/IFOS2), Testicular Ca, Part AIndication(s)
- Testicular Tumor; ICD-10 C62.-
Links
- Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors [clinicaltrials.gov]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 01.04.2020